(Q43654279)

25 November 2017

title

Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease (English)

1 reference

25 November 2017

0 references

0 references

5

1 reference

25 November 2017

Schönknecht P

1

1 reference

25 November 2017

Pantel J

2

1 reference

25 November 2017

Klinga K

3

1 reference

25 November 2017

Jensen M

4

1 reference

25 November 2017

Salbach B

6

1 reference

25 November 2017

Schröder J

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

307

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

122-124

1 reference

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Estrogen and the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

1 reference

7 January 2021

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Potential role for estrogen replacement in the treatment of Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

[Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901896-1

7 January 2021

10.1016/S0304-3940(01)01896-1

Identifiers

DOI

1 reference

25 November 2017

1 reference